Omada Health, Inc.
OMDA· Nasdaq
Released Aug 6, 2026, after the close
10-Q filed Aug 7, 2026, 38 days after period end · 0001628280-26-054840
| Metric | Q2 2026 | Q2 2025 | Q2 2024 |
|---|---|---|---|
| Revenue | $87.84M | $61.37M | $41.21M |
| Net Income | $5.29M | -$5.31M | -$10.69M |
| EPS Diluted | $0.08 | -$0.24 | -$1.40 |
Omada Health, Inc. · CIK 1611115 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.